Cargando…

West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019

In Hungary, West Nile virus (WNV) has been responsible for 459 laboratory confirmed human cases between 2004 and 2019, while the first human Usutu virus (USUV) infection was confirmed only in 2018. A comprehensive serosurvey was conducted among blood donors to assess the WNV and USUV seroprevalence...

Descripción completa

Detalles Bibliográficos
Autores principales: Nagy, Anna, Csonka, Nikolett, Takács, Mária, Mezei, Eszter, Barabás, Éva
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992992/
https://www.ncbi.nlm.nih.gov/pubmed/35395048
http://dx.doi.org/10.1371/journal.pone.0266840
_version_ 1784683819915280384
author Nagy, Anna
Csonka, Nikolett
Takács, Mária
Mezei, Eszter
Barabás, Éva
author_facet Nagy, Anna
Csonka, Nikolett
Takács, Mária
Mezei, Eszter
Barabás, Éva
author_sort Nagy, Anna
collection PubMed
description In Hungary, West Nile virus (WNV) has been responsible for 459 laboratory confirmed human cases between 2004 and 2019, while the first human Usutu virus (USUV) infection was confirmed only in 2018. A comprehensive serosurvey was conducted among blood donors to assess the WNV and USUV seroprevalence in 2019, one year after the largest European WNV epidemic. Altogether, 3005 plasma samples were collected and screened for WNV and USUV specific Immunoglobulin G (IgG) antibodies by Enzyme–Linked Immunosorbent Assay (ELISA). All reactive samples were further tested for tick-borne encephalitis virus IgG antibodies by ELISA. Indirect immunofluorescence test and microneutralization assay were used as confirmatory methods. Overall, the WNV seroprevalence was 4.32%, and in five blood donors USUV seropositivity was confirmed. The highest seroprevalence was measured in Central, Eastern and Southern Hungary, while the Western part of the country proved to be less affected. There was a statistically strong association between the WNV seroprevalence of 2019 and the cumulative incidence in the period of 2004 and 2019 calculated for every NUTS 3 region. The last WNV serological screening was performed in 2016 and the prevalence of anti-WNV IgG proved to be 2.19%. One year after the 2018 WNV outbreak, a significant increase in seroprevalence was observed in the Hungarian population and evidence for USUV seropositivity was also obtained. The spatial pattern of seroprevalence can support the identification of high-risk areas raising awareness of the need for increased surveillance, such as screening vector, equine, and avian populations. The communication with general practitioners and other professionals in primary health care services can support the early identification of acute human cases. Education and awareness-raising on the importance of protection against mosquito vectors amongst residents are also important parts of preventive measures.
format Online
Article
Text
id pubmed-8992992
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-89929922022-04-09 West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019 Nagy, Anna Csonka, Nikolett Takács, Mária Mezei, Eszter Barabás, Éva PLoS One Research Article In Hungary, West Nile virus (WNV) has been responsible for 459 laboratory confirmed human cases between 2004 and 2019, while the first human Usutu virus (USUV) infection was confirmed only in 2018. A comprehensive serosurvey was conducted among blood donors to assess the WNV and USUV seroprevalence in 2019, one year after the largest European WNV epidemic. Altogether, 3005 plasma samples were collected and screened for WNV and USUV specific Immunoglobulin G (IgG) antibodies by Enzyme–Linked Immunosorbent Assay (ELISA). All reactive samples were further tested for tick-borne encephalitis virus IgG antibodies by ELISA. Indirect immunofluorescence test and microneutralization assay were used as confirmatory methods. Overall, the WNV seroprevalence was 4.32%, and in five blood donors USUV seropositivity was confirmed. The highest seroprevalence was measured in Central, Eastern and Southern Hungary, while the Western part of the country proved to be less affected. There was a statistically strong association between the WNV seroprevalence of 2019 and the cumulative incidence in the period of 2004 and 2019 calculated for every NUTS 3 region. The last WNV serological screening was performed in 2016 and the prevalence of anti-WNV IgG proved to be 2.19%. One year after the 2018 WNV outbreak, a significant increase in seroprevalence was observed in the Hungarian population and evidence for USUV seropositivity was also obtained. The spatial pattern of seroprevalence can support the identification of high-risk areas raising awareness of the need for increased surveillance, such as screening vector, equine, and avian populations. The communication with general practitioners and other professionals in primary health care services can support the early identification of acute human cases. Education and awareness-raising on the importance of protection against mosquito vectors amongst residents are also important parts of preventive measures. Public Library of Science 2022-04-08 /pmc/articles/PMC8992992/ /pubmed/35395048 http://dx.doi.org/10.1371/journal.pone.0266840 Text en © 2022 Nagy et al https://creativecommons.org/licenses/by/4.0/This is an open access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
Nagy, Anna
Csonka, Nikolett
Takács, Mária
Mezei, Eszter
Barabás, Éva
West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019
title West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019
title_full West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019
title_fullStr West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019
title_full_unstemmed West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019
title_short West Nile and Usutu virus seroprevalence in Hungary: A nationwide serosurvey among blood donors in 2019
title_sort west nile and usutu virus seroprevalence in hungary: a nationwide serosurvey among blood donors in 2019
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992992/
https://www.ncbi.nlm.nih.gov/pubmed/35395048
http://dx.doi.org/10.1371/journal.pone.0266840
work_keys_str_mv AT nagyanna westnileandusutuvirusseroprevalenceinhungaryanationwideserosurveyamongblooddonorsin2019
AT csonkanikolett westnileandusutuvirusseroprevalenceinhungaryanationwideserosurveyamongblooddonorsin2019
AT takacsmaria westnileandusutuvirusseroprevalenceinhungaryanationwideserosurveyamongblooddonorsin2019
AT mezeieszter westnileandusutuvirusseroprevalenceinhungaryanationwideserosurveyamongblooddonorsin2019
AT barabaseva westnileandusutuvirusseroprevalenceinhungaryanationwideserosurveyamongblooddonorsin2019